James Brian McAlvin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tetrodotoxin | 4 | 2018 | 244 | 0.730 |
Why?
|
| Anesthetics, Local | 4 | 2018 | 1015 | 0.710 |
Why?
|
| Isoflurane | 1 | 2023 | 384 | 0.700 |
Why?
|
| Anesthetics, Inhalation | 1 | 2023 | 573 | 0.610 |
Why?
|
| Sodium Channel Blockers | 2 | 2017 | 170 | 0.580 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2021 | 548 | 0.550 |
Why?
|
| Sciatic Nerve | 3 | 2017 | 628 | 0.530 |
Why?
|
| Anesthesia, Local | 2 | 2015 | 276 | 0.520 |
Why?
|
| Anesthetics, Combined | 1 | 2015 | 43 | 0.490 |
Why?
|
| Saxitoxin | 1 | 2015 | 65 | 0.480 |
Why?
|
| Liposomes | 3 | 2018 | 788 | 0.480 |
Why?
|
| Dexmedetomidine | 3 | 2018 | 316 | 0.480 |
Why?
|
| Clonidine | 1 | 2015 | 165 | 0.460 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 90 | 0.460 |
Why?
|
| Bupivacaine | 2 | 2014 | 432 | 0.430 |
Why?
|
| Cornea | 2 | 2018 | 1316 | 0.370 |
Why?
|
| Antibodies | 1 | 2018 | 2417 | 0.340 |
Why?
|
| Critical Care | 1 | 2021 | 2712 | 0.300 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2007 | 52 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2018 | 8102 | 0.270 |
Why?
|
| Death, Sudden | 1 | 2007 | 300 | 0.250 |
Why?
|
| Cytokines | 1 | 2018 | 7421 | 0.210 |
Why?
|
| Thiocyanates | 1 | 2022 | 70 | 0.200 |
Why?
|
| Nanoparticles | 1 | 2013 | 1964 | 0.180 |
Why?
|
| Injections | 2 | 2014 | 840 | 0.170 |
Why?
|
| Acidosis | 1 | 2022 | 271 | 0.170 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2020 | 51 | 0.170 |
Why?
|
| Rats | 6 | 2018 | 23707 | 0.160 |
Why?
|
| Glycocalyx | 1 | 2020 | 98 | 0.150 |
Why?
|
| Nerve Block | 2 | 2017 | 715 | 0.150 |
Why?
|
| Adrenergic Agonists | 1 | 2017 | 55 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2023 | 1172 | 0.130 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2017 | 204 | 0.130 |
Why?
|
| Vaccination | 1 | 2007 | 3426 | 0.120 |
Why?
|
| Nanotubes | 1 | 2015 | 83 | 0.120 |
Why?
|
| Alkanesulfonic Acids | 1 | 2017 | 199 | 0.120 |
Why?
|
| Drug Delivery Systems | 3 | 2015 | 2207 | 0.110 |
Why?
|
| Epinephrine | 1 | 2017 | 783 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2007 | 3286 | 0.110 |
Why?
|
| Infrared Rays | 1 | 2014 | 246 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 1028 | 0.100 |
Why?
|
| Polyglycolic Acid | 1 | 2013 | 406 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2268 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 939 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2007 | 4697 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2216 | 0.090 |
Why?
|
| Lidocaine | 1 | 2013 | 550 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2013 | 552 | 0.080 |
Why?
|
| Particle Size | 1 | 2013 | 1631 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6493 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2015 | 18973 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2013 | 1137 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 3513 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3584 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4348 | 0.070 |
Why?
|
| Animals | 9 | 2018 | 168764 | 0.070 |
Why?
|
| Immunization Schedule | 1 | 2007 | 228 | 0.060 |
Why?
|
| Thrombosis | 1 | 2020 | 2949 | 0.060 |
Why?
|
| Polymers | 1 | 2013 | 1621 | 0.060 |
Why?
|
| Incidence | 1 | 2023 | 21480 | 0.060 |
Why?
|
| Cell Survival | 1 | 2013 | 5747 | 0.050 |
Why?
|
| Carcinoid Tumor | 1 | 2004 | 225 | 0.050 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2007 | 537 | 0.050 |
Why?
|
| Male | 11 | 2020 | 363698 | 0.050 |
Why?
|
| Appendiceal Neoplasms | 1 | 2004 | 155 | 0.050 |
Why?
|
| Probability | 1 | 2007 | 2475 | 0.050 |
Why?
|
| Brachyura | 1 | 2001 | 18 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2007 | 2910 | 0.050 |
Why?
|
| Cyanides | 1 | 2022 | 82 | 0.050 |
Why?
|
| Chemoreceptor Cells | 1 | 2001 | 87 | 0.050 |
Why?
|
| Antidotes | 1 | 2022 | 138 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2021 | 42500 | 0.050 |
Why?
|
| Appendectomy | 1 | 2004 | 444 | 0.040 |
Why?
|
| Colectomy | 1 | 2004 | 697 | 0.040 |
Why?
|
| Child | 3 | 2023 | 80564 | 0.040 |
Why?
|
| Concanavalin A | 1 | 2018 | 191 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 428 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 765968 | 0.040 |
Why?
|
| Plasma | 1 | 2020 | 579 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2020 | 768 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2018 | 704 | 0.030 |
Why?
|
| Extremities | 1 | 2001 | 869 | 0.030 |
Why?
|
| Diffusion | 1 | 2017 | 808 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 726 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2007 | 2821 | 0.030 |
Why?
|
| Infant | 3 | 2020 | 36386 | 0.030 |
Why?
|
| Nanocomposites | 1 | 2014 | 55 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2017 | 604 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 3675 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 684 | 0.020 |
Why?
|
| Gold | 1 | 2015 | 482 | 0.020 |
Why?
|
| Registries | 1 | 2007 | 8297 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2001 | 2643 | 0.020 |
Why?
|
| Light | 1 | 2015 | 1365 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4427 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2007 | 26346 | 0.020 |
Why?
|
| Wound Healing | 1 | 2018 | 2792 | 0.020 |
Why?
|
| Motor Activity | 1 | 2017 | 2704 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2007 | 24282 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 39193 | 0.020 |
Why?
|
| Mice | 1 | 2013 | 81819 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3481 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10729 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2007 | 41649 | 0.010 |
Why?
|
| Female | 6 | 2022 | 396112 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2007 | 1831 | 0.010 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2001 | 113 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 2001 | 497 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20124 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40065 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81514 | 0.010 |
Why?
|
| Action Potentials | 1 | 2001 | 1838 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1865 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 88835 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2001 | 1445 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 9649 | 0.010 |
Why?
|
| Adult | 2 | 2007 | 223044 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 59489 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2004 | 65188 | 0.000 |
Why?
|
| Aged | 1 | 2004 | 171117 | 0.000 |
Why?
|
| Middle Aged | 1 | 2004 | 223009 | 0.000 |
Why?
|